[Heat shock protein 90 alpha und beta are overexpressed in multiple myeloma cells and critically contribute to survival].
HSP90's are overexpressed in different cancer types and they probably are required to sustain aberrant signalling in malignant cells. Recently, pharmacological inhibition of HSP90 was found to suppress growth of myeloma cell lines and in primary myeloma cells. Therefore, we wanted to investigate the role of HSP90alpha and HSP90beta in the pathogenesis of malignant myeloma (MM) in more detail. Immunohistochemistry was employed to examine the expression of HSP90alpha and HSP90beta in MM. The importance of HSP90 for survival of MM -cells was investigated by SiRNA-mediated knockdown of HSP90 and blockade of the IL-6R/STAT3 and the MAPK signaling pathways in vitro. HSP90alpha and HSP90beta were overexpressed in majority of investigated MM cases, but not in MGUS or in normal plasma cells. SiRNA-mediated knockdown of HSP90 or treatment with the novel HSP90 inhibitor 17-DMAG attenuated the levels of STAT3 and phospho-ERK and decreased the viability of MM cells. The knockdown of HSP90alpha was sufficient to induce apoptosis. This effect was strongly increased when both HSP90s were targeted, indicating a cooperation of both. HSP90 critically contributes to myeloma survival in the context of its microenvironment and therefore strengthen the potential value of HSP90 as a therapeutic target.
Andrulis
M
M
Institut für Pathologie, Universitätsklinikum Heidelberg.
Chatterjee
M
M
Jain
S
S
Stühmer
T
T
Ungethüm
U
U
Kuban
R J
RJ
Lorentz
H
H
Bommert
K
K
Topp
M
M
Kramer
D
D
Müller-Hermelinks
H K
HK
Einsele
H
H
Bargou
R C
RC
Greiner
A
A